524572 — Pharmaids Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.75bn
- IN₹1.77bn
- IN₹151.12m
Annual cashflow statement for Pharmaids Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.75 | 0.884 | 1.4 | -99.1 | -156 |
| Depreciation | |||||
| Non-Cash Items | 0 | 0 | 0 | 0.352 | 21.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.11 | 2.72 | -4.09 | 58.4 | 11.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7.48 | 4.05 | -2.59 | -40.2 | -106 |
| Capital Expenditures | -0.424 | -0.015 | — | -16.7 | -229 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 7.03 | -2.25 | 4.67 | -32.7 | -521 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 6.61 | -2.27 | 4.67 | -49.4 | -750 |
| Financing Cash Flow Items | -0 | — | 0 | 0 | -12.4 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0 | 0 | 0 | 213 | 777 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.87 | 1.79 | 2.07 | 123 | -79.5 |